---
title: "12 Health Care Stocks Moving In Friday's Pre-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285722413.md"
description: "In Friday's pre-market session, Traws Pharma (NASDAQ:TRAW) shares surged 37% to $2.33, while Amylyx Pharmaceuticals (NASDAQ:AMLX) rose 18.42% to $18.0. Other gainers included Celldex Therapeutics (NASDAQ:CLDX) up 12.54% to $37.5, and InMed Pharmaceuticals (NASDAQ:INM) up 12% to $0.78. Conversely, Sensus Healthcare (NASDAQ:SRTS) fell 25.1% to $3.08, Absci (NASDAQ:ABSI) dropped 19.66% to $4.62, and Amphastar Pharma (NASDAQ:AMPH) decreased 15.65% to $20.27. Most companies reported Q1 earnings yesterday."
datetime: "2026-05-08T12:05:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285722413.md)
  - [en](https://longbridge.com/en/news/285722413.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285722413.md)
---

# 12 Health Care Stocks Moving In Friday's Pre-Market Session

### Gainers

-   **Traws Pharma** (NASDAQ:TRAW) shares increased by 37.0% to $2.33 during Friday's pre-market session. The market value of their outstanding shares is at $17.2 million.
-   **Amylyx Pharmaceuticals** (NASDAQ:AMLX) stock increased by 18.42% to $18.0. The company's market cap stands at $1.6 billion. The company's, Q1 earnings came out yesterday.
-   **Celldex Therapeutics** (NASDAQ:CLDX) stock moved upwards by 12.54% to $37.5. The market value of their outstanding shares is at $2.6 billion. As per the news, the Q1 earnings report came out yesterday.
-   **InMed Pharmaceuticals** (NASDAQ:INM) stock rose 12.0% to $0.78. The company's market cap stands at $2.3 million.
-   **Progyny** (NASDAQ:PGNY) stock moved upwards by 10.17% to $21.11. The company's market cap stands at $1.6 billion. The company's, Q1 earnings came out yesterday.
-   **Artiva Biotherapeutics** (NASDAQ:ARTV) stock increased by 9.82% to $13.75. The company's market cap stands at $307.3 million. As per the news, the Q1 earnings report came out today.

### Losers

-   **Sensus Healthcare** (NASDAQ:SRTS) shares decreased by 25.1% to $3.08 during Friday's pre-market session. The company's market cap stands at $67.6 million. As per the news, the Q1 earnings report came out yesterday.
-   **Absci** (NASDAQ:ABSI) stock decreased by 19.66% to $4.62. The company's market cap stands at $893.8 million. The company's, Q1 earnings came out yesterday.
-   **Amphastar Pharma** (NASDAQ:AMPH) shares fell 15.65% to $20.27. The company's market cap stands at $1.0 billion. As per the press release, Q1 earnings came out yesterday.
-   **Capricor Therapeutics** (NASDAQ:CAPR) stock decreased by 13.97% to $29.2. The company's market cap stands at $1.9 billion.
-   **Organogenesis Holdings** (NASDAQ:ORGO) stock fell 13.84% to $2.18. The company's market cap stands at $320.9 million. The company's, Q1 earnings came out yesterday.
-   **Artivion** (NYSE:AORT) shares decreased by 12.5% to $30.99. The company's market cap stands at $1.6 billion. As per the press release, Q1 earnings came out yesterday. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [INM.US](https://longbridge.com/en/quote/INM.US.md)
- [AMLX.US](https://longbridge.com/en/quote/AMLX.US.md)
- [SRTS.US](https://longbridge.com/en/quote/SRTS.US.md)
- [AMPH.US](https://longbridge.com/en/quote/AMPH.US.md)
- [CLDX.US](https://longbridge.com/en/quote/CLDX.US.md)
- [TRAW.US](https://longbridge.com/en/quote/TRAW.US.md)
- [ABSI.US](https://longbridge.com/en/quote/ABSI.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [PGNY.US](https://longbridge.com/en/quote/PGNY.US.md)
- [ARTV.US](https://longbridge.com/en/quote/ARTV.US.md)
- [CAPR.US](https://longbridge.com/en/quote/CAPR.US.md)
- [ORGO.US](https://longbridge.com/en/quote/ORGO.US.md)
- [AORT.US](https://longbridge.com/en/quote/AORT.US.md)

## Related News & Research

- [Amylyx Pharmaceuticals Eyes Phase 3 AVEXITIDE Readout as 2027 Launch Comes Into Focus](https://longbridge.com/en/news/286360144.md)
- [Roth MKM Sticks to Their Buy Rating for Capricor Therapeutics (CAPR)](https://longbridge.com/en/news/286497683.md)
- [BUZZ-Street View: Regeneron's melanoma trial setback raises bigger-picture questions](https://longbridge.com/en/news/286769076.md)
- [Leerink Partners Sticks to Their Buy Rating for Ibio (IBIO)](https://longbridge.com/en/news/286588262.md)
- [Traws Pharma reports Q1 net loss  on higher R&D expenses](https://longbridge.com/en/news/286553923.md)